Day: October 28, 2020

MONTRÉAL, 28 oct. 2020 (GLOBE NEWSWIRE) — Redevances Aurifères Osisko Ltée (« Redevances Osisko ») (TSX et NYSE : OR) et Barolo Ventures Corp. (« Barolo ») (TSX-V : BVC.H) ont le plaisir de communiquer les derniers développements concernant leur opération de transfert d’actifs annoncée précédemment, en complément de leur communiqué conjoint daté du 5 octobre 2020, qui conduira à une « prise de contrôle inversée » de Barolo (la « PCI ») en vertu des politiques de la Bourse de croissance TSX (le « TSX-V »). Dans le présent communiqué, toute référence à l’« émetteur résultant » ou à « Osisko Développement » renvoie à Barolo après la clôture de la PCI.Signature de la convention de fusion définitiveLe 23 octobre 2020, une convention de fusion définitive (la « convention de fusion ») relative à la PCI a été signée par Redevances Osisko,...

Unless otherwise noted, all financial figures are unaudited, presented in Canadian dollars (Cdn$), and have been prepared in accordance with International Financial Reporting Standards, specifically International Accounting Standard 34 Interim Financial Reporting as issued by the International Accounting Standards Board. Production volumes are presented on a working–interest basis, before royalties, except for production volumes from the company’s Libyan operations, which are presented on an economic basis. Certain financial measures referred to in this news release (funds from operations, operating (loss) earnings and free funds flow) are not prescribed by Canadian generally accepted accounting principles (GAAP). See the Non-GAAP Financial Measures section of this news release. References to Oil Sands operations exclude Suncor...

À moins d’indication contraire, toute l’information financière est non auditée, est présentée en dollars canadiens ($ CA) et a été établie conformément aux Normes internationales d’information financière, plus précisément la Norme comptable internationale 34 Information financière intermédiaire publiée par l’International Accounting Standards Board. Les volumes de production sont présentés selon la participation directe avant redevances, sauf pour les volumes de production liés aux activités de la Société en Libye, qui sont présentés en fonction des principes économiques. Certaines mesures financières du présent communiqué (fonds provenant de l’exploitation, bénéfice (perte) d’exploitation et flux de fonds disponibles) ne sont pas prescrites par les principes comptables généralement reconnus (les « PCGR ») du Canada. Voir la rubrique...

MONTERREY, Mexico, Oct. 28, 2020 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD) announced today its operational and financial results for the third quarter of 2020.Eduardo Padilla, FEMSA’s CEO, commented:“The third quarter was again challenging across our operations, but it appears we hit the lockdown-driven bottom in the middle of the second quarter, and from there we are seeing consistent, if gradual, improvement across our business units. At OXXO, same-store sales for the third quarter were still lower than last year but sequentially they show a better picture and trend than what we saw three months ago. This reflects a strong average ticket but still a double-digit contraction in average traffic as mobility remains depressed, and regulatory restrictions are still broadly in place...

MONTERREY, México, Oct. 28, 2020 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD) anuncia sus resultados operativos y financieros para el tercer trimestre del 2020.Eduardo Padilla, Director General de FEMSA, comentó:“El tercer trimestre fue retador en todas nuestras operaciones, pero al parecer tocamos el fondo causado por el confinamiento a la mitad del segundo trimestre, y de ahí hemos visto una mejoría consistente, aunque gradual, a través de nuestras unidades de negocio. En OXXO, nuestras ventas mismas-tiendas siguieron por debajo del año pasado, pero secuencialmente muestran un mejor nivel y tendencia que lo que vimos hace tres meses. Esto refleja un robusto ticket promedio, pero también una contracción de doble dígito en el tráfico promedio efecto de una movilidad todavía deprimida,...

Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in in drug discovery and preclinical oncology and immuno-oncology services, announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 909,091 shares of common stock of the Company at a price to the public of $2.20 per share, less underwriting discounts and commissions. The offering is expected to close on or about November 2, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company has also granted to the underwriter a 30-day option to purchase up to an additional 136,363 shares of common...

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces that it has re-filed certain press releases in accordance with comments issued by the Ontario Securities Commission. Red Pine included links to certain pictures and tables in the press releases dated May 28, 2029, June 13, 2019 and June 21, 2019. These press releases have been refiled to include the relevant figures in the body of these press releases, rather than linking to them.In addition, the press release dated May 28, 2019 has been amended to break out the grade or quality and the quantity for each category of mineral resource rather than presenting them as a total-ounce estimate and grade as originally presented, and the statement therein providing that Red Pine has “improved the economics of the resource”...

MORRISVILLE, N.C., Oct. 28, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced an agreement to acquire Synteract, a full-service CRO focused on the rapidly growing emerging biopharma segment.Synteract has built a leading reputation among emerging biopharma, providing deep therapeutic expertise in oncology, rare and orphan diseases, neuroscience, dermatology, and pediatrics. Synteract’s client base comprises primarily pre-revenue companies, a segment in which Syneos Health has growth opportunities. Synteract’s 700 employees across North America, Europe, Asia Pacific and Africa have supported more than 4,000 Phase I-IV clinical trials across 26,000 sites...

SACRAMENTO, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) — Pacific Ethanol, Inc. (NASDAQ: PEIX), a leading producer of specialty alcohols and essential ingredients, today announced the closing of its previously announced underwritten public offering of common stock and pre-funded warrants and concurrent private offering of warrants, for total gross proceeds of approximately $75.0 million.The company closed an underwritten public offering of 5,075,000 shares of its common stock at a public offering price of $8.42 per share and 5-year pre-funded warrants to purchase 3,825,493 shares of common stock at a public offering price of $8.42 per pre-funded warrant. In addition, in a concurrent private placement, the company also issued to investors, for a nominal price, warrants to purchase an additional 8,900,493 shares of common stock at an exercise...